The Medication Recommendation Tracking Form

A novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness research

Noreen A. Reilly-Harrington, Louisa G. Sylvia, Andrew C. Leon, Leah W. Shesler, Terence A. Ketter, Charles L. Bowden, Joseph R. Calabrese, Edward S. Friedman, Michael J. Ostacher, Dan V. Iosifescu, Dustin J. Rabideau, Michael E. Thase, Andrew A. Nierenberg

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

This paper describes the development and use of the Medication Recommendation Tracking Form (MRTF), a novel method for capturing physician prescribing behavior and clinical decision making. The Bipolar Trials Network developed and implemented the MRTF in a comparative effectiveness study for bipolar disorder (LiTMUS). The MRTF was used to assess the frequency, types, and reasons for medication adjustments. Changes in treatment were operationalized by the metric Necessary Clinical Adjustments (NCA), defined as medication adjustments to reduce symptoms, optimize treatment response and functioning, or to address intolerable side effects. Randomized treatment groups did not differ in rates of NCAs, however, responders had significantly fewer NCAs than non-responders. Patients who had more NCAs during their previous visit had significantly lower odds of responding at the current visit. For each one-unit increase in previous CGI-BP depression score and CGI-BP overall severity score, patients had an increased NCA rate of 13% and 15%, respectively at the present visit. Ten-unit increases in previous Montgomery Asberg Depression Rating Scale (MADRS) and Young Mania Rating Scale (YMRS) scores resulted in an 18% and 14% increase in rates of NCAs, respectively. Patients with fewer NCAs had increased quality of life and decreased functional impairment. The MRTF standardizes the reporting and rationale for medication adjustments and provides an innovative metric for clinical effectiveness. As the first tool in psychiatry to track the types and reasons for medication changes, it has important implications for training new clinicians and examining clinical decision making. (ClinicalTrials.gov number NCT00667745).

Original languageEnglish (US)
Pages (from-to)1686-1693
Number of pages8
JournalJournal of Psychiatric Research
Volume47
Issue number11
DOIs
StatePublished - Nov 2013

Fingerprint

Comparative Effectiveness Research
Social Adjustment
Bipolar Disorder
Depression
Psychiatry
Therapeutics
Quality of Life
Clinical Decision-Making
Clinical Decision Making
Medication
Physicians

Keywords

  • Bipolar disorder
  • Comparative effectiveness research
  • Medication algorithms
  • Medication tracking

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Arts and Humanities (miscellaneous)

Cite this

The Medication Recommendation Tracking Form : A novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness research. / Reilly-Harrington, Noreen A.; Sylvia, Louisa G.; Leon, Andrew C.; Shesler, Leah W.; Ketter, Terence A.; Bowden, Charles L.; Calabrese, Joseph R.; Friedman, Edward S.; Ostacher, Michael J.; Iosifescu, Dan V.; Rabideau, Dustin J.; Thase, Michael E.; Nierenberg, Andrew A.

In: Journal of Psychiatric Research, Vol. 47, No. 11, 11.2013, p. 1686-1693.

Research output: Contribution to journalArticle

Reilly-Harrington, NA, Sylvia, LG, Leon, AC, Shesler, LW, Ketter, TA, Bowden, CL, Calabrese, JR, Friedman, ES, Ostacher, MJ, Iosifescu, DV, Rabideau, DJ, Thase, ME & Nierenberg, AA 2013, 'The Medication Recommendation Tracking Form: A novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness research', Journal of Psychiatric Research, vol. 47, no. 11, pp. 1686-1693. https://doi.org/10.1016/j.jpsychires.2013.07.009
Reilly-Harrington, Noreen A. ; Sylvia, Louisa G. ; Leon, Andrew C. ; Shesler, Leah W. ; Ketter, Terence A. ; Bowden, Charles L. ; Calabrese, Joseph R. ; Friedman, Edward S. ; Ostacher, Michael J. ; Iosifescu, Dan V. ; Rabideau, Dustin J. ; Thase, Michael E. ; Nierenberg, Andrew A. / The Medication Recommendation Tracking Form : A novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness research. In: Journal of Psychiatric Research. 2013 ; Vol. 47, No. 11. pp. 1686-1693.
@article{bf6d1389365f4e1c9003622e92979a79,
title = "The Medication Recommendation Tracking Form: A novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness research",
abstract = "This paper describes the development and use of the Medication Recommendation Tracking Form (MRTF), a novel method for capturing physician prescribing behavior and clinical decision making. The Bipolar Trials Network developed and implemented the MRTF in a comparative effectiveness study for bipolar disorder (LiTMUS). The MRTF was used to assess the frequency, types, and reasons for medication adjustments. Changes in treatment were operationalized by the metric Necessary Clinical Adjustments (NCA), defined as medication adjustments to reduce symptoms, optimize treatment response and functioning, or to address intolerable side effects. Randomized treatment groups did not differ in rates of NCAs, however, responders had significantly fewer NCAs than non-responders. Patients who had more NCAs during their previous visit had significantly lower odds of responding at the current visit. For each one-unit increase in previous CGI-BP depression score and CGI-BP overall severity score, patients had an increased NCA rate of 13{\%} and 15{\%}, respectively at the present visit. Ten-unit increases in previous Montgomery Asberg Depression Rating Scale (MADRS) and Young Mania Rating Scale (YMRS) scores resulted in an 18{\%} and 14{\%} increase in rates of NCAs, respectively. Patients with fewer NCAs had increased quality of life and decreased functional impairment. The MRTF standardizes the reporting and rationale for medication adjustments and provides an innovative metric for clinical effectiveness. As the first tool in psychiatry to track the types and reasons for medication changes, it has important implications for training new clinicians and examining clinical decision making. (ClinicalTrials.gov number NCT00667745).",
keywords = "Bipolar disorder, Comparative effectiveness research, Medication algorithms, Medication tracking",
author = "Reilly-Harrington, {Noreen A.} and Sylvia, {Louisa G.} and Leon, {Andrew C.} and Shesler, {Leah W.} and Ketter, {Terence A.} and Bowden, {Charles L.} and Calabrese, {Joseph R.} and Friedman, {Edward S.} and Ostacher, {Michael J.} and Iosifescu, {Dan V.} and Rabideau, {Dustin J.} and Thase, {Michael E.} and Nierenberg, {Andrew A.}",
year = "2013",
month = "11",
doi = "10.1016/j.jpsychires.2013.07.009",
language = "English (US)",
volume = "47",
pages = "1686--1693",
journal = "Journal of Psychiatric Research",
issn = "0022-3956",
publisher = "Elsevier Limited",
number = "11",

}

TY - JOUR

T1 - The Medication Recommendation Tracking Form

T2 - A novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness research

AU - Reilly-Harrington, Noreen A.

AU - Sylvia, Louisa G.

AU - Leon, Andrew C.

AU - Shesler, Leah W.

AU - Ketter, Terence A.

AU - Bowden, Charles L.

AU - Calabrese, Joseph R.

AU - Friedman, Edward S.

AU - Ostacher, Michael J.

AU - Iosifescu, Dan V.

AU - Rabideau, Dustin J.

AU - Thase, Michael E.

AU - Nierenberg, Andrew A.

PY - 2013/11

Y1 - 2013/11

N2 - This paper describes the development and use of the Medication Recommendation Tracking Form (MRTF), a novel method for capturing physician prescribing behavior and clinical decision making. The Bipolar Trials Network developed and implemented the MRTF in a comparative effectiveness study for bipolar disorder (LiTMUS). The MRTF was used to assess the frequency, types, and reasons for medication adjustments. Changes in treatment were operationalized by the metric Necessary Clinical Adjustments (NCA), defined as medication adjustments to reduce symptoms, optimize treatment response and functioning, or to address intolerable side effects. Randomized treatment groups did not differ in rates of NCAs, however, responders had significantly fewer NCAs than non-responders. Patients who had more NCAs during their previous visit had significantly lower odds of responding at the current visit. For each one-unit increase in previous CGI-BP depression score and CGI-BP overall severity score, patients had an increased NCA rate of 13% and 15%, respectively at the present visit. Ten-unit increases in previous Montgomery Asberg Depression Rating Scale (MADRS) and Young Mania Rating Scale (YMRS) scores resulted in an 18% and 14% increase in rates of NCAs, respectively. Patients with fewer NCAs had increased quality of life and decreased functional impairment. The MRTF standardizes the reporting and rationale for medication adjustments and provides an innovative metric for clinical effectiveness. As the first tool in psychiatry to track the types and reasons for medication changes, it has important implications for training new clinicians and examining clinical decision making. (ClinicalTrials.gov number NCT00667745).

AB - This paper describes the development and use of the Medication Recommendation Tracking Form (MRTF), a novel method for capturing physician prescribing behavior and clinical decision making. The Bipolar Trials Network developed and implemented the MRTF in a comparative effectiveness study for bipolar disorder (LiTMUS). The MRTF was used to assess the frequency, types, and reasons for medication adjustments. Changes in treatment were operationalized by the metric Necessary Clinical Adjustments (NCA), defined as medication adjustments to reduce symptoms, optimize treatment response and functioning, or to address intolerable side effects. Randomized treatment groups did not differ in rates of NCAs, however, responders had significantly fewer NCAs than non-responders. Patients who had more NCAs during their previous visit had significantly lower odds of responding at the current visit. For each one-unit increase in previous CGI-BP depression score and CGI-BP overall severity score, patients had an increased NCA rate of 13% and 15%, respectively at the present visit. Ten-unit increases in previous Montgomery Asberg Depression Rating Scale (MADRS) and Young Mania Rating Scale (YMRS) scores resulted in an 18% and 14% increase in rates of NCAs, respectively. Patients with fewer NCAs had increased quality of life and decreased functional impairment. The MRTF standardizes the reporting and rationale for medication adjustments and provides an innovative metric for clinical effectiveness. As the first tool in psychiatry to track the types and reasons for medication changes, it has important implications for training new clinicians and examining clinical decision making. (ClinicalTrials.gov number NCT00667745).

KW - Bipolar disorder

KW - Comparative effectiveness research

KW - Medication algorithms

KW - Medication tracking

UR - http://www.scopus.com/inward/record.url?scp=84884418749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884418749&partnerID=8YFLogxK

U2 - 10.1016/j.jpsychires.2013.07.009

DO - 10.1016/j.jpsychires.2013.07.009

M3 - Article

VL - 47

SP - 1686

EP - 1693

JO - Journal of Psychiatric Research

JF - Journal of Psychiatric Research

SN - 0022-3956

IS - 11

ER -